Increased plasma nicotinamide phosphoribosyltransferase (NAMPT) is associated with a hyperproliferative phenotype and restrains disease progression in MPN‐associated myelofibrosis
In conclusion, in MPN‐associated myelofibrosis high levels of eNAMPT mark the myeloproliferative potential and, at variance with a high number of cancers, are protective against disease progression. This article is protected by copyright. All rights reserved.
Source: American Journal of Hematology - Category: Hematology Authors: Vittorio Rosti, Rita Campanelli, Margherita Massa, Gianluca Viarengo, Laura Villani, Valentina Poletto, Elisa Bonetti, Paolo Catarsi, Umberto Magrini, Ambra A. Grolla, Cristina Travelli, Armando A. Genazzani, Giovanni Barosi Tags: Research Article Source Type: research
More News: Cancer | Cancer & Oncology | Hematology | Myeloproliferative Disorders | Stem Cell Therapy | Stem Cells | Study | Thrombocytopenia